Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Phaos Technology Holdings Cayman EV-to-EBIT?
Phaos Technology Holdings CaymanPOAS -6.08%4 EV-to-EBIT is -1.06 as of Jul. 26, 2026. GuruFocus rates POAS with a GF Score™ of 4/100. The stock has 5 warning signs investors should review. Among 467 Medical Devices & Instruments companies, Phaos Technology Holdings Cayman ranks worse than 214132.55% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Phaos Technology Holdings Cayman's Enterprise Value for the quarter that ended in Oct. 2025 was $0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Phaos Technology Holdings Cayman's EBIT for the trailing twelve months (TTM) ended in Oct. 2025 was $-3.51 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phaos Technology Holdings Cayman EV-to-EBIT Related Terms
Phaos Technology Holdings Cayman EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Phaos Technology Holdings Cayman's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phaos Technology Holdings Cayman EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Phaos Technology Holdings Cayman's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Phaos Technology Holdings Cayman's EV-to-EBIT falls into.
Phaos Technology Holdings Cayman's current Enterprise Value is $3.71 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Phaos Technology Holdings Cayman's EBIT for the trailing twelve months (TTM) ended in Oct. 2025 was $-3.51 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phaos Technology Holdings Cayman (POAS) has a EV-to-EBIT of -1.06 as of Jul. 26, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Phaos Technology Holdings Cayman and its competitors. According to the industry distribution chart, Phaos Technology Holdings Cayman ranks #999999 out of 467 companies in the Medical Devices & Instruments industry.
Is Phaos Technology Holdings Cayman's EV-to-EBIT too high?
Phaos Technology Holdings Cayman's current EV-to-EBIT is -1.06. Based on the distribution chart, Phaos Technology Holdings Cayman ranks #999999 out of 467 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Phaos Technology Holdings Cayman has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Phaos Technology Holdings Cayman's EV-to-EBIT compare to WOK and ITOC?
According to the Medical Devices & Instruments industry distribution chart, Phaos Technology Holdings Cayman ranks #999999 out of 467 companies for EV-to-EBIT. This places Phaos Technology Holdings Cayman in the lower half of its industry. The industry median EV-to-EBIT is 18.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.21, based on 467 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Phaos Technology Holdings Cayman and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phaos Technology Holdings Cayman's current EV-to-EBIT is -1.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phaos Technology Holdings Cayman stock overvalued right now?
Phaos Technology Holdings Cayman (POAS) has a current EV-to-EBIT of -1.06. The current EV-to-EBIT is -1.06. Phaos Technology Holdings Cayman's overall GF Score™ is 4/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Phaos Technology Holdings Cayman (POAS), the current EV-to-EBIT is -1.06 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Phaos Technology Holdings Cayman Business Description
Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of advanced optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers advanced microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.
4GF Score
Get the complete analysis for POAS
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
POAS has been successfully added to your 
